Jared Holz, Mizuho healthcare sector strategist, joins ‘Fast Money’ to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz
May 18, 2023
